Search
Find exactly what you’re looking for.
Search

Showing 61-80 of 90 results

Zachary Kobrin spoke on a panel titled, “Opportunities and Challenges in the 2023 Cannabis Market” presented by Centri Business Consulting. This webinar featured a panel of experts discussing trending financial topics in the cannabis industry including: Recent updates in Capital Markets & SAFE...
On November 9, 2022, the New York Department of Financial Services (“NYDFS”) published proposed amendments (the “Proposed Amendments”) to its Cybersecurity Regulations (23 NYCRR 500), commonly referred to as Reg. 500. The comment period for these Proposed Amendments ends on January 9, 2023...

This month’s Friday Five covers cases relating to discovery in ERISA benefits cases, an appellate court strictly interpreting ERISA regulatory deadlines, a district court authorizing an ERISA breach of fiduciary duty claim based on alleged misrepresentations from an employer, another district court...
​As the cannabis industry continues to grow and expand at a rapid pace, successful operators could become the targets of labeling class actions that have plagued the traditional food and beverage industry for decades, especially in plaintiff-friendly jurisdictions like California. Suits related to...

This month’s Friday Five explores recent decisions that illustrate the importance of the administrative record built by a claims administrator, and the impact that the depth and thoroughness of the record will have on litigation over claims decisions. Whether reviewing claims under the de novo...
​As interest in psychedelics rises, amidst the decriminalization of psychedelic substances in various jurisdictions and the regulation of the provision of psilocybin services in Oregon, institutions of higher education may find themselves wondering how to navigate the myriad questions that come...

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

Zachary Kobrin spoke on a panel titled, “Mock Negotiation: Buying/Selling A License” at The Marijuana Business Conference (MJBizCon) Cannabis Law Sessions presented by The International Cannabis Bar Association (INCBA). This panel featured a mock negotiation of the purchase/sale of a cannabis...

This month’s Friday Five covers cases relating to augmentation of the administrative record following new rationales, attempted alternative ERISA causes of action, untimely ERISA claims, plans governed by ERISA even in the absence of a written plan document, and the limited weight given to residual...

Stephanie Denker, an Associate at Saul Ewing, LLP, will be speaking at the ARIAS Fall Conference on November 4, 2022. This session, Rapid Fire Case Presentations, was such a success in years past, it's being brought back for 2022! Hear from five presenters as they compete to convince the audience...

Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the 2022 Rowan University Cannabis Forum: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session will cover the implications of cannabis legislation on businesses and...

Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the Rowan University Cannabis Forum 2022: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session is entitled "Implications of Cannabis Legislation on Businesses...

Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will speak during the 2022 Tobacco/OTP + CBD Forum in Orlando, FL.

MAKING SENSE OF PRES. BIDEN’S CANNABIS REFORM STATEMENT – FDA’S ROLE IN SCHEDULING EVALUATION Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will discuss President Biden’s recent cannabis reform announcement, its implications for various stakeholders, and FDA’s role in evaluating how...

This month’s Friday Five covers cases relating to the interpretation of time periods for claims under life insurance and disability plans, a situation where three separate administrators handled a disability benefits claim (but came to different decisions), the Eleventh Circuit’s parsing of...

INTO THE RABBIT HOLE OF PSYCHEDELICS: EXPLORING MDMA, PSILOCYBIN, LSD, AYAHUASCA, DMT, IBOGAINE, KETAMINE, AND OTHER PSYCHEDELICS. Jonathan Havens, Co-Chair of the Firm's Cannabis Practice, will be speaking at the Psychedelic Medicine Conference/CBD Expo. Jonathan's panel will dive down the rabbit...

Jonathan Havens, Co-Chair of Saul Ewing's Cannabis Law Practice, will speak at The Cannabis and Psychedelics Investment Summit in London on September 20, 2022. Jonathan will be joining a panel entitled "A Legal Overview: The Future of Cannabis and Psychedelic Policy."
For More Information
Contact us